MacKenzie Realty Capital Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2023-12-31; filed 2024-02-13.
0001140361-24-007491
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2024-03-31; filed 2024-05-15.
0001140361-24-026184
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 8 previous paragraphs and 9 current paragraphs.
7 unchanged; 1 reworded; 1 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 5 previous and 6 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes to our risk factors discussed in “Risk Factors” in our annual report on Form 10-K for the fiscal year ended June 30, 2023.
Added paragraphs (1)
Reworded paragraphs (1)
Previous wording
During the six months ended December 31, 2023, we issued 68,808.31 of Series A preferred shares with total gross proceeds of $1,718,951, 4,444.44 of Series B preferred shares with total gross proceeds of $100,000, and 3,713.55 Series A preferred shares with total gross proceeds of $83,556 under the DRIP related to the Series A preferred, pursuant to our Regulation A Series A and Series B preferred stock offering.
Current wording
During the nine months ended March 31, 2024, we issued 80,280.31 of Series A preferred shares with total gross proceeds of $2,005,751, 16,612.44 of Series B preferred shares with total gross proceeds of $404,200, and 5,719.07 Series A preferred shares with total gross proceeds of $128,679 under the DRIP related to the Series A preferred, pursuant to our Regulation A Series A and Series B preferred stock offering.